Answers are grounded in this paper and cite their sources.
Highlights a rare but life-threatening adverse effect (thrombocytopenia) associated with eptifibatide use.
Eptifibatide is a commonly and widely used drug for management of acute coronary syndrome and during percutaneous coronary intervention. It is usually well tolerated with no major adverse effects. We report a rare case of life-threatening thrombocytopenia secondary to eptifibatide along with a literature review of available evidence.
No takes yet. Share an insight, caveat, or question.
Pothineni et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: